Atlas Trials

Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV

Clinical trial NCT00198393 · COMPLETED

Trial details

NCT number
NCT00198393
Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2004-11-01
Primary completion
2008-06-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.